Blue Sail Medical Co.Ltd(002382)
Independent opinions of independent directors on matters related to the 21st Meeting of the Fifth Board of directors
As an independent director of Blue Sail Medical Co.Ltd(002382) (hereinafter referred to as the “company”), in accordance with the company law of the people’s Republic of China (hereinafter referred to as the “company law”), the stock listing rules of Shenzhen Stock Exchange and the guidelines for the standardized operation of listed companies of Shenzhen stock exchange According to the opinions on establishing an independent director system in listed companies and the requirements of the Blue Sail Medical Co.Ltd(002382) articles of Association (hereinafter referred to as the “articles of association”), we express independent opinions on the relevant matters of the 21st Meeting of the Fifth Board of directors as follows:
1、 Independent opinions on cooperative investment funds between subsidiaries and professional investment institutions
Shandong Jiwei Medical Products Co., Ltd. participated in the investment fund this time, which helps to expand the investment channels of the company and its subsidiaries and increase investment income by relying on the rich management experience of professional investment institutions and the advantages and resources of each partner. The deliberation and voting procedures of the investment fund matters comply with the relevant provisions of laws and regulations and the articles of association. The decision-making procedures are legal and effective, and there is no situation that damages the interests of minority shareholders of the company. Therefore, we agree that our subsidiaries cooperate with professional investment institutions to invest in the fund.
2、 Independent opinions on the proposed internal asset restructuring
The company will invest and transfer the assets and liabilities related to the health protection gloves business to the wholly-owned subsidiary according to the net book value, which is conducive to further improving the company’s management structure and will not have a significant adverse impact on the company’s financial status and operating results. The deliberation procedure of this matter complies with the relevant provisions of laws and regulations and the articles of association, and will not damage the interests of the company and shareholders. Therefore, we agree to the internal asset restructuring.
3、 Independent opinions on the appointment of the president of the company
After verification, we believe that:
1. Considering the company’s long-term strategic inheritance, incremental business development and the age echelon construction of the company’s management team, Ms. Liu Wenjing applied to no longer hold the post of president, and the reason for resignation is consistent with the actual situation;
2. Mr. Zhong Shuqiao meets the qualifications of senior managers of listed companies, has the necessary working experience to perform relevant duties, and the relevant nomination and appointment procedures comply with the relevant provisions of laws and regulations and the articles of association. There is no situation that he is prohibited from holding office as stipulated in the company law or is determined as a market prohibited person by the CSRC and has not been lifted, Nor is there any situation that the stock exchange determines as an inappropriate candidate.
In conclusion, we agree that the company appoints Mr. Zhong Shuqiao as the president of the company, and the term of office starts from the date of deliberation and approval by the board of directors to the date of expiration of the term of office of the Fifth Board of directors.
(no text below)
(there is no text on this page, which is the signature page of Blue Sail Medical Co.Ltd(002382) independent directors’ independent opinions on matters related to the 21st Meeting of the Fifth Board of directors)
Signature of independent director:
Liu Shengjun, Dong Shukui, Gong bengao
January 13, 2002
